Lynch Regenerative Medicine
Lynch Regenerative Medicine is a startup headquartered in Franklin, United States, founded in 2023. It has raised at least $3.8m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Lynch Regenerative Medicine has raised at least $3.8m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Lynch Regenerative Medicine sits inside the Nashville R&D ecosystem in the Global R&D Labs Directory.
Other startups in Franklin
Related
- Innovation profile of Franklin
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Lynch Regenerative Medicine do?
Lynch Regenerative Medicine is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has Lynch Regenerative Medicine raised?
At least $3.8m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Lynch Regenerative Medicine based?
Lynch Regenerative Medicine is headquartered in Franklin, United States.
When was Lynch Regenerative Medicine founded?
Lynch Regenerative Medicine was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.